EP1343370A4 - Souche bacterienne, extraits de plantes traites, compositions a base de ces elements, procedes relatifs a leur elaboration, et leurs applications therapeutiques et industrielles - Google Patents

Souche bacterienne, extraits de plantes traites, compositions a base de ces elements, procedes relatifs a leur elaboration, et leurs applications therapeutiques et industrielles

Info

Publication number
EP1343370A4
EP1343370A4 EP01998302A EP01998302A EP1343370A4 EP 1343370 A4 EP1343370 A4 EP 1343370A4 EP 01998302 A EP01998302 A EP 01998302A EP 01998302 A EP01998302 A EP 01998302A EP 1343370 A4 EP1343370 A4 EP 1343370A4
Authority
EP
European Patent Office
Prior art keywords
therapeutic
processes
preparation
compositions containing
bacterial strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP01998302A
Other languages
German (de)
English (en)
Other versions
EP1343370A2 (fr
Inventor
Mark Olshenitsky
Genadi Buchman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Balance Corp
Original Assignee
Bio Balance Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/725,846 external-priority patent/US6500423B2/en
Application filed by Bio Balance Corp filed Critical Bio Balance Corp
Publication of EP1343370A2 publication Critical patent/EP1343370A2/fr
Publication of EP1343370A4 publication Critical patent/EP1343370A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/84—Flavour masking or reducing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
EP01998302A 2000-11-30 2001-11-27 Souche bacterienne, extraits de plantes traites, compositions a base de ces elements, procedes relatifs a leur elaboration, et leurs applications therapeutiques et industrielles Ceased EP1343370A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US725846 2000-11-30
US09/725,846 US6500423B2 (en) 1999-06-03 2000-11-30 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
PCT/IL2001/001088 WO2002043649A2 (fr) 2000-11-30 2001-11-27 Souche bacterienne, extraits de plantes traites, compositions a base de ces elements, procedes relatifs a leur elaboration, et leurs applications therapeutiques et industrielles

Publications (2)

Publication Number Publication Date
EP1343370A2 EP1343370A2 (fr) 2003-09-17
EP1343370A4 true EP1343370A4 (fr) 2004-02-11

Family

ID=24916190

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01998302A Ceased EP1343370A4 (fr) 2000-11-30 2001-11-27 Souche bacterienne, extraits de plantes traites, compositions a base de ces elements, procedes relatifs a leur elaboration, et leurs applications therapeutiques et industrielles

Country Status (14)

Country Link
EP (1) EP1343370A4 (fr)
JP (1) JP4410992B2 (fr)
KR (1) KR20030082549A (fr)
CN (1) CN1294253C (fr)
AU (2) AU2100402A (fr)
BR (1) BR0116178A (fr)
CA (1) CA2430292A1 (fr)
IL (1) IL156213A0 (fr)
MX (1) MXPA03004851A (fr)
NZ (1) NZ526748A (fr)
PL (1) PL366363A1 (fr)
RU (1) RU2281326C2 (fr)
WO (1) WO2002043649A2 (fr)
ZA (1) ZA200304747B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212975D0 (en) 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
IL152127A0 (en) 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
MXPA06001821A (es) * 2003-08-18 2006-05-31 Bio Balance Corp Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma.
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
WO2007136719A2 (fr) * 2006-05-18 2007-11-29 Biobalance Llc Compositions thérapeutiques et leurs utilisations
RU2453320C2 (ru) * 2008-08-05 2012-06-20 Виктор Владимирович Чалов Композиция для перорального применения, содержащая непатогенные микроорганизмы, обладающая способностью нормализовать микрофлору кишечника (варианты)
KR101127171B1 (ko) * 2009-07-24 2012-03-20 (주)애드바이오텍 오리의 급만성 전염질병을 유발하는 병원체에 대한 항체를 지닌 난황을 함유하는 오리 사료 첨가용 조성물
AU2011253984A1 (en) 2010-12-07 2012-06-28 Biobalance Llc Method For Identifying E. Coli M-17
RU2458527C1 (ru) * 2010-12-30 2012-08-20 Общество с ограниченной ответственностью "БИОТРОФ" Способ получения препарата для кормления сельскохозяйственных животных и птицы и способ приготовления корма на его основе
RS57056B1 (sr) 2012-07-20 2018-05-31 Prevtec Microbia Inc Nepatogeni soj f18 e.coli i njegova primena
ES2940463T3 (es) 2012-09-25 2023-05-08 Aquilon Cyl S L Composiciones probióticas y prebióticas
EP3628161B1 (fr) * 2012-11-23 2023-04-05 Seres Therapeutics, Inc. Compositions bactériennes synergiques et leurs procédés de production et d'utilisation
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CN110917220A (zh) 2013-02-04 2020-03-27 赛里斯治疗公司 治疗组合物及其使用方法
EP3904502A3 (fr) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions et procédés
US9717726B2 (en) 2013-03-14 2017-08-01 Maregade Rx, LLC Product and method for treating diarrhea
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
RU2722482C2 (ru) 2013-11-25 2020-06-01 Серес Терапеутикс, Инк. Синергические бактериальные композиции и способы их получения и применения
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
RU2660355C2 (ru) * 2016-04-01 2018-07-05 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Антибактериальная фармацевтическая композиция для перорального применения, содержащая бактериофаги
BR112018075853A2 (pt) * 2016-06-14 2019-03-19 Prevtec Microbia Inc. ração animal incluindo um aditivo de ração animal, método de produção e uso da mesma.
RU2639544C1 (ru) * 2016-12-16 2017-12-21 Общество с ограниченной ответственностью "БИОРЕАКТОР" Средство для лечения и профилактики заболеваний желудочно-кишечного тракта птицы
WO2018119464A1 (fr) 2016-12-23 2018-06-28 Maregade Rx, LLC Produit à faible dose et méthode de traitement de la diarrhée
CN107319103A (zh) * 2017-08-01 2017-11-07 河南牧业经济学院 促进畜禽生长和肠道发育的饲料添加剂及其制备方法和应用
CN111212655A (zh) 2017-08-14 2020-05-29 赛里斯治疗公司 用于治疗胆汁淤积性疾病的组合物和方法
KR101939080B1 (ko) * 2017-10-23 2019-01-16 고려대학교 산학협력단 슈도모나스 베로니 균주 kacc 81051bp 및 이를 포함하는 조성물
CN109260235A (zh) * 2018-10-23 2019-01-25 上海市第十人民医院 一种组合物在制备防治便秘药物或保健品中的应用
CN110004072B (zh) * 2018-11-12 2021-08-13 西安交通大学 一株益生性粪肠球菌分离株a3-1及其应用
CN113652340A (zh) * 2021-08-24 2021-11-16 江苏江大源生态生物科技股份有限公司 一种益生菌制剂、菌种筛选装置及筛选方法
CN113616715B (zh) * 2021-08-31 2022-05-06 昆明理工大学 治疗仔猪腹泻及改善其肠道菌群的发酵中药口服液

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501098A (en) * 1974-06-11 1978-02-15 Brewing Patents Ltd Preparation of hop oil
WO1996037210A2 (fr) * 1995-05-26 1996-11-28 Ropapharm B.V. I.O. Compositions pharmaceutiques a base d'huile etheriques obtenues a partir de plantes presentant des applications en medecine humaine et veterinaire
WO1999008532A1 (fr) * 1997-08-13 1999-02-25 University Of Georgia Research Foundation, Inc. Lutte contre l'entero-hemorragie du betail, provoquee par e. coli o157:h7, a l'aide de bacteries probiotiques
WO2000075284A1 (fr) * 1999-06-03 2000-12-14 The Bio Balance Corporation Souche bacterienne, extraits de plantes traites et composition probiotique a usage medical et veterinaire

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908028A (en) * 1973-04-19 1975-09-23 Procter & Gamble Soft drink composition containing paramethoxycinnamaldehyde as a flavoring agent and sweetner
US4986985A (en) * 1987-11-02 1991-01-22 Bar Ilan University Method of treating skin virus infections
CH675685A5 (fr) * 1988-06-24 1990-10-31 Flachsmann Ag Emil
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5082489A (en) * 1990-02-06 1992-01-21 The Royal Institution For The Advancement Of Learning (Mcgill University) Composition for biocontrol of wild buckwheat
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5486367A (en) * 1992-10-13 1996-01-23 Kansas State University Research Foundation Enzymatic method for accelerating fermentation of comestible products
US5376374A (en) * 1993-05-24 1994-12-27 Zelaya; Luz M. Oral rinse composition
US5733774A (en) * 1995-02-02 1998-03-31 Ecoscience Corporation Method and composition for producing stable bacteria and bacterial formulations
AU714310B2 (en) * 1995-05-12 1999-12-23 Japan Pharmaceutical Development Co., Ltd Plant extract
US5679364A (en) * 1995-06-07 1997-10-21 Lee County Mosquito Control District Compositions and methods for reducing the amount of contaminants in aquatic and terrestrial environments
GB2303799B (en) * 1995-07-29 1999-03-10 Siemens Plc Improvements in or relating to aqueous sample testing apparatus
US5888395A (en) * 1996-08-30 1999-03-30 The Regents Of The University Of California Method for enhanced longevity of in situ microbial filter used for bioremediation
US5773075A (en) * 1996-12-13 1998-06-30 Kalamazoo Holdings, Inc. High temperature countercurrent solvent extraction of Capsicum solids

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501098A (en) * 1974-06-11 1978-02-15 Brewing Patents Ltd Preparation of hop oil
WO1996037210A2 (fr) * 1995-05-26 1996-11-28 Ropapharm B.V. I.O. Compositions pharmaceutiques a base d'huile etheriques obtenues a partir de plantes presentant des applications en medecine humaine et veterinaire
WO1999008532A1 (fr) * 1997-08-13 1999-02-25 University Of Georgia Research Foundation, Inc. Lutte contre l'entero-hemorragie du betail, provoquee par e. coli o157:h7, a l'aide de bacteries probiotiques
WO2000075284A1 (fr) * 1999-06-03 2000-12-14 The Bio Balance Corporation Souche bacterienne, extraits de plantes traites et composition probiotique a usage medical et veterinaire

Also Published As

Publication number Publication date
WO2002043649A3 (fr) 2002-08-29
KR20030082549A (ko) 2003-10-22
IL156213A0 (en) 2003-12-23
EP1343370A2 (fr) 2003-09-17
WO2002043649A2 (fr) 2002-06-06
JP2004534512A (ja) 2004-11-18
AU2002221004B2 (en) 2007-01-25
CN1494374A (zh) 2004-05-05
BR0116178A (pt) 2003-10-14
RU2281326C2 (ru) 2006-08-10
MXPA03004851A (es) 2004-05-04
JP4410992B2 (ja) 2010-02-10
PL366363A1 (en) 2005-01-24
WO2002043649A8 (fr) 2004-04-29
CN1294253C (zh) 2007-01-10
AU2100402A (en) 2002-06-11
NZ526748A (en) 2006-03-31
CA2430292A1 (fr) 2002-06-06
ZA200304747B (en) 2004-09-03

Similar Documents

Publication Publication Date Title
IL156213A0 (en) Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
AU8685901A (en) High growth methanotrophic bacterial strain
IL130303A0 (en) A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
EP1438075A4 (fr) Procedes et compositions se rapportant a des vecteurs lentiviraux a expression reduite et leurs applications
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HK1073618A1 (en) Enhanced formulations for neutralization of chemical, biological and industrial toxants
EG22839A (en) Process and plant
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
HUP0303006A3 (en) Retinoids for the treatment of emphysema, process for their preparation and pharmaceutical compositions containing them
AU2002224080A1 (en) Gene Hd3a inducing flowering of plant and utilization thereof
IL151823A0 (en) Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
AU2078001A (en) Modification of floral scent in flowering plants
IL155678A0 (en) Antimicrobial 2-pyridones, their compositions and uses
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2002357356A1 (en) Novel antifungal bacterium and compositions
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
AUPQ248399A0 (en) Plant and product treatment
AU2001284277A1 (en) Chemical process and plant
HUP0401038A3 (en) Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them
AU2002219295A1 (en) Disinfecting peroxosilicated compound with scale preventive effect, preparation method and use thereof
AU2001211674A1 (en) Naphthomelanins, process for their preparation and compositions thereof
IL159333A0 (en) Plant treatment composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030623

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20031230

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1058882

Country of ref document: HK

17Q First examination report despatched

Effective date: 20070126

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20090619

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1058882

Country of ref document: HK